MentalHealthDaily

Pharmacogenomics (PGx) for Depression: Genetic Analysis to Amplify Antidepressant Efficacy? (2023 Review)

by GLOOM

Depression, a leading cause of disability globally, often presents challenges in treatment due to the variability in individual responses to antidepressants. Pharmacogenomic (PGx) testing, an approach aligning treatment with genetic makeup, promises to tailor depression therapy more effectively. Highlights: Major Depressive Disorder (MDD) impacts a significant portion of the global population, with traditional treatments often …

Antidepressants & Dementia Risk in Elderly Users: SSRIs vs. TCAs (2024 Study)

by GLOOM

Recent research has uncovered connections between the use of antidepressants and the risk of developing dementia in the elderly. This complex relationship, marked by varying results and considerations, is becoming a critical area of study in geriatric medicine and mental health. In light of these findings, it is crucial to delve into the nuances of …

Psychedelics for Depression: Targeting the 5-HT2A Receptor & Beyond (2023 Study)

by GLOOM

The quest for effective treatments for Major Depressive Disorder (MDD) has taken a revolutionary turn with the exploration of psychedelic compounds. Recent research has evaluated the potential of substances like psilocybin and lisuride, offering new hope for patients unresponsive to traditional antidepressants. Highlights: Traditional Limitations: Standard antidepressants often fail to provide relief for 30% of …

Lateral Habenula & Depression: The Anti-Reward Center (Mechanisms & Antidepressant Treatments)

by GLOOM

Depression is a complex and multifaceted disorder affecting millions worldwide. Emerging evidence suggests the lateral habenula, a small brain region, plays a crucial role in depression’s development and persistence. By influencing neurotransmitter systems and interacting with stress pathways, the lateral habenula’s dysfunction may lead to the classic symptoms of depression. Highlights: The lateral habenula is …

Polyphenols & Depression: Antidepressant Potential of Plant Compounds

by GLOOM

Depression, a prevalent and debilitating mental health condition, affects millions worldwide. Recent studies have shown an intriguing link between dietary polyphenols, naturally occurring compounds in plant-based foods, and depression outcomes. Highlights: Prevalence of Depression: More than 300 million people globally suffer from depression, marking it as a leading cause of disability. Role of Polyphenols: Polyphenols, …

Antidepressants, Bacterial Mutations, & Antibiotic Resistance?

by GLOOM

Antibiotics have long been the cornerstone of modern medicine, but their effectiveness is increasingly threatened by the rise of antibiotic resistance. While the overuse of antibiotics is a well-acknowledged culprit, recent research reveals a surprising and relatively unexplored contributor: antidepressants. Highlights: Antidepressants and Resistance: Antidepressants, particularly those used in large quantities like SSRIs and SNRIs, …

Best Antidepressants for Preventing Depression Relapse & Maintenance Treatment (Study)

by GLOOM

Depression is a complex, often long-term condition requiring careful management. Recent research has shed light on the effectiveness of various antidepressants during the maintenance phase of major depressive disorder (MDD). Highlights: Extensive Study: The meta-analysis included 34 double-blind, placebo-controlled trials with a total of 9,384 participants. Multiple Drugs Analyzed: 20 different antidepressants were compared for …